Ritesh Rajesh Kotecha

Ritesh Rajesh Kotecha serves as an Assistant Professor in the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSKCC), specializing within the Solid Tumor Oncology Division's Genitourinary Oncology Service. His academic appointment is explicitly confirmed through institutional listings under the Hematologic Malignancies Division and Weinberg Fellows program.

Dr. Kotecha's research focuses on molecular characterization of genitourinary malignancies, particularly renal cell carcinoma (RCC) subtypes and urothelial carcinoma. His work investigates KEAP1-mutated RCC, metabolic adaptations in clear/non-clear cell RCC, and real-world outcomes of novel antibody-drug conjugates like sacituzumab govitecan. Key themes include biomarker discovery, therapeutic resistance mechanisms, and clinical translation of molecular findings.

His publication trends (94 total works including 47 meeting abstracts and 39 journal articles) demonstrate deep engagement with renal cancer biology and GU oncology therapeutics. Recent high-impact work appears in Journal of Clinical Oncology (35 publications), European Urology, and Clinical Cancer Research.

Scientific contributions include:

• Characterization of emerging RCC molecular subtypes
• Cancer metabolism studies in renal tumors
• Clinical evaluation of sequential targeted therapies

Dr. Kotecha maintains extensive collaborations across MSKCC, with 65 co-authors including prominent researchers like Voss (62 collaborations), Motzer (43), and Carlo (42). His work spans clinical trials, molecular oncology, and real-world evidence generation without indication of dedicated laboratory leadership.